Gap in the low $5's filled Friday by my taking although some feel full body candles are necessary, I don't
That said...post ASCO may still see some more work on the lower end depending on actual data presented and of course months before approval.
We shall see
Whoops...forgot to add.....CFO leaving for new job
Wall Street Titan wrote: I expect a quick rebound from today's equity raise decline in VSTM shares. Has priority review date of October 5th for oral oncology drug that has met endpoints. $100,000,000 cash in the bank now. Stock had been strong and should rebound quickly. Easy 20% within a month or so, IMHO, but do your own DD.
Your estimate of a 20% increase in VSTM was certainly conservative - it has almost doubled in a month!
PS AS OF 6/19 - with regard to the disaster unfolding in the price of ATHX, I notice that you don't seem to post on either of the two ATHX MB's when the stock is tanking - I guess just a good news guy, LOL.